| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.03 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |